Investor Presentaiton slide image

Investor Presentaiton

Research paper (properties of virus) Non-clinical study (eg.Biodistribution) Information obtained administration route, doses,·· from use abroad Risk Assessment Study design Containment Measures "Type 1 Use Regulations" "Biological Diversity Risk Assessment Report"
View entire presentation